347 related articles for article (PubMed ID: 23514552)
1. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
[TBL] [Abstract][Full Text] [Related]
2. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease.
Takatsu N; Matsui T; Murakami Y; Ishihara H; Hisabe T; Nagahama T; Maki S; Beppu T; Takaki Y; Hirai F; Yao K
J Gastroenterol Hepatol; 2009 Jul; 24(7):1258-64. PubMed ID: 19682195
[TBL] [Abstract][Full Text] [Related]
3. Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease.
Pashazadeh P; Marjani A; Asadi J; Khoshnia M
Endocr Metab Immune Disord Drug Targets; 2019; 19(4):541-547. PubMed ID: 30451123
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
5. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M
Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
[TBL] [Abstract][Full Text] [Related]
6. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
[TBL] [Abstract][Full Text] [Related]
7. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece.
Coucoutsi C; Emmanouil G; Goulielmos G; Sfakianaki O; Koutroubakis IE; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1284-1289. PubMed ID: 28857898
[TBL] [Abstract][Full Text] [Related]
9. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
10. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacogenomics of thiopurine S-methyltransferase.
Zhou S
Curr Clin Pharmacol; 2006 Jan; 1(1):119-28. PubMed ID: 18666383
[TBL] [Abstract][Full Text] [Related]
12. Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.
Di Salvo A; Fabiano C; Mannara V; Dimarco M; Orlando A; Affronti M; Macaluso FS; Cottone M
Dig Liver Dis; 2016 Dec; 48(12):1506-1509. PubMed ID: 27665263
[TBL] [Abstract][Full Text] [Related]
13. Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis.
Liu YP; Xu HQ; Li M; Yang X; Yu S; Fu WL; Huang Q
PLoS One; 2015; 10(12):e0144234. PubMed ID: 26633017
[TBL] [Abstract][Full Text] [Related]
14. TPMT Genotype and Adverse Effects of Azathioprine among Jordanian Group.
Mhanna M; Gharaibeh MG; Rashid M; Sharab A; Shehab M; Zihlif M
Curr Drug Metab; 2019; 20(11):889-897. PubMed ID: 31631819
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.
Gearry RB; Barclay ML; Burt MJ; Collett JA; Chapman BA; Roberts RL; Kennedy MA
Aliment Pharmacol Ther; 2003 Aug; 18(4):395-400. PubMed ID: 12940924
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
Zhu Q; Cao Q
Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease.
Dong XW; Zheng Q; Zhu MM; Tong JL; Ran ZH
World J Gastroenterol; 2010 Jul; 16(25):3187-95. PubMed ID: 20593505
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
Odahara S; Uchiyama K; Kubota T; Ito Z; Takami S; Kobayashi H; Saito K; Koido S; Ohkusa T
PLoS One; 2015; 10(9):e0137798. PubMed ID: 26360046
[TBL] [Abstract][Full Text] [Related]
19. Comparison of
Wang HH; He Y; Wang HX; Liao CL; Peng Y; Tao LJ; Zhang W; Yang HX
World J Gastroenterol; 2018 Feb; 24(8):941-948. PubMed ID: 29491687
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients.
Desatova B; Hlavaty T; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Kadasi L; Huorka M; Batovsky M
Bratisl Lek Listy; 2013; 114(6):330-2. PubMed ID: 23731044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]